Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored With the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored With the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
"Innovation in imaging science is essential for advancing biomedicine," said Dr. Mallick. "I am truly honored to receive this prestigious award from the Academy and join its Council of Distinguished Investigators. This honor is a testament to the advances my lab members, partners, and colleagues have helped make possible."Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research's esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging
Mallick博士因在医疗影像领域做出杰出贡献，将被选入放射学和生物医药影像研究院卓越调查员委员会。
SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced Nautilus co-founder and Chief Scientist Parag Mallick, Ph.D., was bestowed the 2024 Distinguished Investigator (DI) Award by the Academy for Radiology and Biomedical Imaging Research (the Academy).
2024年10月31日，Nautilus生物技术公司（纳斯达克股票代码：NAUT； 或 "鹦鹉螺体育"），是一家开创性的单分子蛋白质分析平台公司，用于量化蛋白质组，今天宣布，Nautilus 共同创始人兼首席科学家 Parag Mallick 博士荣获2024年度放射学和生物医学影像研究学院（Academy）颁发的杰出研究员（DI）奖。
The Award recognizes Dr. Mallick's notable achievements in the field of imaging research, including his decades-long leadership, high-impact publications, and ongoing research and development contributions.
该奖项表彰了 Mallick 博士在成像研究领域的显著成就，包括他数十年来的领导、高影响力出版物，以及持续的研究和开发贡献。
"Innovation in imaging science is essential for advancing biomedicine," said Dr. Mallick. "I am truly honored to receive this prestigious award from the Academy and join its Council of Distinguished Investigators. This honor is a testament to the advances my lab members, partners, and colleagues have helped make possible."
"创新的成像科学对推动生物医学至关重要，" Mallick 博士说。"能获得学院颁发的这一殊荣并加入其杰出研究员委员会，我深感荣幸。这一荣誉证明了我的实验室成员、合作伙伴和同事们帮助实现的进步。"
"Parag continues to prove his unwavering commitment to scientific excellence and the improvement of human health," said Sujal Patel, Chief Executive Officer of Nautilus. "His accomplishments over the course of his career are many, with each bringing our entire industry a step closer to unlocking critical biological insights."
苏杰尔·帕特尔，鹦鹉螺体育首席执行官说：“帕拉格继续证明了他对科学卓越和改善人类健康的坚定承诺。他职业生涯中的成就众多，每一项都让整个行业更接近于揭示重要的生物信息。”
Dr. Mallick will be inducted into the Academy's Council of Distinguished Investigators during the Annual Meeting of the Radiological Society of North America (RSNA) taking place December 1-5, 2024 in Chicago, Illinois.
Mallick博士将于2024年12月1日至5日在伊利诺伊州芝加哥举行的北美放射学会（RSNA）年会期间被引入学院的杰出研究员委员会。
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit .
关于Nautilus Biotechnology，Inc。
鹦鹉螺体育总部位于西雅图，研发总部位于旧金山湾区，是一家生命科学公司，正在开发阶段创建一种用于量化和解锁蛋白质组复杂性的平台技术。鹦鹉螺体育的使命是通过使蛋白质组 democratizing 访问蛋白质组，并促进人类健康和医学的基础进展。要了解更多关于鹦鹉螺体育的信息，请访问 .
Media Contact
press@nautilus.bio
媒体联系
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
投资者联系人
investorrelations@nautilus.bio
A photo accompanying this announcement is available at
此公告附带的照片
